tiprankstipranks
ANGLE plc’s HER2 Assay Gains Independent Validation at San Antonio Symposium
Company Announcements

ANGLE plc’s HER2 Assay Gains Independent Validation at San Antonio Symposium

Story Highlights

Pick the best stocks and maximize your portfolio:

An announcement from ANGLE plc ( (GB:AGL) ) is now available.

ANGLE plc announced the presentation of independent findings by Weill Cornell Medicine at the San Antonio Breast Cancer Symposium, supporting ANGLE’s HER2 assay development program. The Parsortix-based HER2 workflow could revolutionize patient stratification for treatment with HER2 antibody drug conjugates (ADCs) by providing a semi-automated, quantitative assessment of HER2 status in circulating tumor cells (CTCs). This is particularly impactful as HER2 status often changes over time, and the new method could allow for real-time assessment, enabling better-targeted treatments and potentially expanding the eligibility for ADC therapies to patients previously classified as HER2-negative.

More about ANGLE plc

ANGLE plc is a leading company in the liquid biopsy industry, specializing in innovative circulating tumor cell (CTC) solutions applicable in research, drug development, and clinical oncology. Their flagship technology, the Parsortix® PC1 System, is FDA cleared and used for comprehensive analysis of blood samples to aid in diagnostics and personalized medicine.

YTD Price Performance: -4.09%

Average Trading Volume: 1,295,286

Technical Sentiment Consensus Rating: Buy

Current Market Cap: £36.28M

For an in-depth examination of AGL stock, go to TipRanks’ Stock Analysis page.

Related Articles
TipRanks UK Auto-Generated NewsdeskANGLE plc Showcases New HER2 Assay Developments
TipRanks UK Auto-Generated NewsdeskANGLE plc Showcases Innovative Liquid Biopsy for Cancer
Looking for investment ideas? Subscribe to our Smart Investor newsletter for weekly expert stock picks!
Get real-time notifications on news & analysis, curated for your stock watchlist. Download the TipRanks app today! Get the App